Clinical Trial Update: Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating RNA derived from liver tissue in patients with chronic hepatitis C has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED